US Stock MarketDetailed Quotes
RYTM Rhythm Pharmaceuticals
- 56.120
- +0.640+1.15%
Close Dec 20 16:00 ET
- 56.120
- 0.0000.00%
Post 20:01 ET
3.45BMarket Cap-12.99P/E (TTM)
58.160High55.465Low1.52MVolume55.590Open55.480Pre Close85.75MTurnover3.37%Turnover RatioLossP/E (Static)61.46MShares68.58052wk High308.35P/B2.53BFloat Cap35.17052wk Low--Dividend TTM45.06MShs Float68.580Historical High--Div YieldTTM4.86%Amplitude3.040Historical Low56.414Avg Price1Lot Size
Rhythm Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -0.29%298.39M | 25.84%319.13M | -31.70%201.2M | -17.23%275.85M | -17.23%275.85M | -13.96%299.26M | 7.64%253.6M | 22.25%294.58M | 13.03%333.29M | 13.03%333.29M |
| -Cash and cash equivalents | -26.43%47.52M | 39.75%161.67M | -51.28%53.43M | -52.94%60.08M | -52.94%60.08M | -65.10%64.59M | 2.19%115.68M | 39.63%109.66M | 115.50%127.68M | 115.50%127.68M |
| -Short-term investments | 6.90%250.87M | 14.17%157.46M | -20.09%147.77M | 4.94%215.77M | 4.94%215.77M | 44.23%234.67M | 12.69%137.92M | 13.85%184.92M | -12.73%205.61M | -12.73%205.61M |
| Receivables | 32.77%19.31M | 27.24%17.6M | 81.04%14.7M | 138.87%14.87M | 138.87%14.87M | 336.93%14.54M | 710.25%13.83M | 841.65%8.12M | 507.22%6.22M | 507.22%6.22M |
| -Accounts receivable | 32.77%19.31M | 27.24%17.6M | 81.04%14.7M | 138.87%14.87M | 138.87%14.87M | 336.93%14.54M | 710.25%13.83M | 841.65%8.12M | 507.22%6.22M | 507.22%6.22M |
| Inventory | 79.01%13.9M | 94.14%11.99M | 55.04%8.51M | 195.65%8.62M | 195.65%8.62M | --7.76M | --6.18M | --5.49M | 2,527.93%2.92M | 2,527.93%2.92M |
| Prepaid assets | ---- | ---- | ---- | -48.57%2.26M | -48.57%2.26M | ---- | ---- | ---- | -47.74%4.39M | -47.74%4.39M |
| Other current assets | 14.56%8.75M | -15.81%8.64M | 17.61%11.35M | -10.02%6.67M | -10.02%6.67M | -28.96%7.64M | -14.65%10.27M | -16.96%9.65M | 85.75%7.42M | 85.75%7.42M |
| Total current assets | 3.38%340.34M | 25.89%357.37M | -25.83%235.75M | -12.98%308.27M | -12.98%308.27M | -9.03%329.2M | 13.86%283.88M | 25.41%317.84M | 14.87%354.24M | 14.87%354.24M |
| Non current assets | ||||||||||
| Net PPE | 80.39%4.39M | 68.98%4.67M | -41.11%1.82M | -37.20%2.12M | -37.20%2.12M | -34.23%2.43M | -29.48%2.76M | -25.82%3.09M | -22.05%3.38M | -22.05%3.38M |
| -Gross PPE | 80.39%4.39M | 68.98%4.67M | -41.11%1.82M | -5.40%6.18M | -5.40%6.18M | -34.23%2.43M | -29.48%2.76M | -25.82%3.09M | -0.89%6.53M | -0.89%6.53M |
| -Accumulated depreciation | ---- | ---- | ---- | -28.65%-4.06M | -28.65%-4.06M | ---- | ---- | ---- | -39.73%-3.16M | -39.73%-3.16M |
| Goodwill and other intangible assets | -11.79%6.39M | -11.47%6.6M | -11.14%6.82M | -10.85%7.03M | -10.85%7.03M | -10.56%7.24M | -10.29%7.46M | -10.06%7.67M | 69.24%7.88M | 69.24%7.88M |
| -Other intangible assets | -11.79%6.39M | -11.47%6.6M | -11.14%6.82M | ---- | ---- | --7.24M | --7.46M | --7.67M | ---- | ---- |
| Other non current assets | -18.72%12.45M | -16.64%13.21M | -16.50%14.26M | -9.75%15.33M | -9.75%15.33M | -3.89%15.32M | -1.66%15.85M | -8.57%17.08M | 39.86%16.98M | 39.86%16.98M |
| Total non current assets | -7.07%23.23M | -6.08%24.48M | -17.75%22.9M | -13.34%24.48M | -13.34%24.48M | -9.88%25M | -8.04%26.07M | -11.27%27.84M | 33.63%28.25M | 33.63%28.25M |
| Total assets | 2.65%363.57M | 23.20%381.85M | -25.18%258.65M | -13.00%332.75M | -13.00%332.75M | -9.09%354.2M | 11.62%309.94M | 21.37%345.68M | 16.07%382.48M | 16.07%382.48M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 27.30%4.89M | -45.81%4.54M | -43.43%7.55M | 1.83%4.89M | 1.83%4.89M | -22.18%3.84M | 39.44%8.38M | 11.13%13.35M | -16.38%4.8M | -16.38%4.8M |
| -accounts payable | 27.30%4.89M | -45.81%4.54M | -43.43%7.55M | 1.83%4.89M | 1.83%4.89M | -22.18%3.84M | 39.44%8.38M | 11.13%13.35M | -16.38%4.8M | -16.38%4.8M |
| Current accrued expenses | 24.59%50.48M | 28.17%42.3M | 31.03%36.33M | 40.61%42.85M | 40.61%42.85M | 95.10%40.52M | 4.82%33M | 17.21%27.73M | 4.07%30.48M | 4.07%30.48M |
| Current debt and capital lease obligation | ---- | 12.40%816K | 12.48%793K | 12.57%770K | 12.57%770K | 12.65%748K | 12.73%726K | 12.80%705K | 12.87%684K | 12.87%684K |
| -Current capital lease obligation | --0 | 12.40%816K | 12.48%793K | 12.57%770K | 12.57%770K | 12.65%748K | 12.73%726K | 12.80%705K | 12.87%684K | 12.87%684K |
| Current deferred liabilities | 0.00%1.29M | 0.00%1.29M | -9.94%1.29M | -10.32%1.29M | -10.32%1.29M | -52.67%1.29M | -64.48%1.29M | -84.87%1.43M | -79.51%1.43M | -79.51%1.43M |
| Other current liabilities | 991.10%40.95M | 113.61%5.78M | 190.44%8.2M | 123.65%5.41M | 123.65%5.41M | -6.55%3.75M | -3.74%2.7M | 82.90%2.82M | 202.38%2.42M | 202.38%2.42M |
| Current liabilities | 94.65%97.61M | 18.70%54.72M | 17.66%54.16M | 38.67%55.2M | 38.67%55.2M | 51.50%50.14M | 3.44%46.1M | -2.63%46.03M | -8.33%39.81M | -8.33%39.81M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 482.37%4.03M | 271.73%3.3M | -73.61%284K | -61.11%490K | -61.11%490K | -51.94%692K | -44.98%888K | -39.58%1.08M | -35.22%1.26M | -35.22%1.26M |
| -Long term capital lease obligation | 482.37%4.03M | 271.73%3.3M | -73.61%284K | -61.11%490K | -61.11%490K | -51.94%692K | -44.98%888K | -39.58%1.08M | -35.22%1.26M | -35.22%1.26M |
| Non current deferred liabilities | 4.34%109.24M | 36.58%108.37M | 38.50%107.37M | 40.01%106.14M | 40.01%106.14M | 43.50%104.7M | 131.51%79.35M | --77.52M | --75.81M | --75.81M |
| Derivative product liabilities | --0 | -72.73%360K | -48.84%660K | -14.18%1.15M | -14.18%1.15M | 29.35%1.19M | -16.98%1.32M | --1.29M | --1.34M | --1.34M |
| Preferred securities outside stock equity | --141.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current liabilities | ---- | --35.6M | --34.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | 139.02%254.75M | 81.02%147.63M | 78.89%142.91M | 37.46%107.78M | 37.46%107.78M | 41.50%106.58M | 117.61%81.56M | 4,385.46%79.89M | 3,931.36%78.41M | 3,931.36%78.41M |
| Total liabilities | 124.83%352.36M | 58.51%202.35M | 56.51%197.07M | 37.87%162.99M | 37.87%162.99M | 44.55%156.73M | 55.59%127.66M | 156.68%125.92M | 160.55%118.22M | 160.55%118.22M |
| Shareholders'equity | ||||||||||
| Share capital | 3.39%61K | 245,885.96%140.21M | 7.14%60K | 5.36%59K | 5.36%59K | 5.36%59K | 14.00%57K | 12.00%56K | 12.00%56K | 12.00%56K |
| -common stock | 3.39%61K | 5.26%60K | 7.14%60K | 5.36%59K | 5.36%59K | 5.36%59K | 14.00%57K | 12.00%56K | 12.00%56K | 12.00%56K |
| -Preferred stock | --0 | --140.15M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -30.35%-1.11B | -32.07%-1.07B | -35.93%-1.04B | -26.01%-894.74M | -26.01%-894.74M | -27.79%-853.1M | -29.08%-808.94M | -31.04%-762.24M | -34.24%-710.06M | -34.24%-710.06M |
| Paid-in capital | 6.96%1.12B | 11.81%1.11B | 11.80%1.1B | 9.23%1.06B | 9.23%1.06B | 10.70%1.05B | 20.41%991.18M | 20.04%981.95M | 19.84%974.36M | 19.84%974.36M |
| Gains losses not affecting retained earnings | -434.51%-604K | -4,307.14%-617K | -2,916.67%-181K | 245.65%134K | 245.65%134K | 66.67%-113K | 98.45%-14K | 99.05%-6K | -9,100.00%-92K | -9,100.00%-92K |
| Total stockholders'equity | -94.32%11.22M | -1.53%179.5M | -71.98%61.58M | -35.76%169.76M | -35.76%169.76M | -29.77%197.47M | -6.82%182.29M | -6.79%219.76M | -7.00%264.26M | -7.00%264.26M |
| Total equity | -94.32%11.22M | -1.53%179.5M | -71.98%61.58M | -35.76%169.76M | -35.76%169.76M | -29.77%197.47M | -6.82%182.29M | -6.79%219.76M | -7.00%264.26M | -7.00%264.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data